NTLA  200619C00025000

Bought NTLA $25 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Oswin

intellia therapeutic’s core mission is to develop curative medicines, utilizing the promise of the crispr/cas9 gene editing technology.   the development of crispr/cas9 gene editing technology opens a new frontier in biomedical research and clinical interv

Intellia Therapeutics, Inc

New position in NTLA

Bought 1125% more NTLA

Sold all NTLA

Anthony

Aaron Roberts

Eric Weiner

Sold 50% of NTLA

Camden Jones

Aaron

Bought 100% more NTLA

Sold 67% of NTLA

Six Montahue

Sold 40% of NTLA

Sold 44% of NTLA

Sold 31% of NTLA

Sold 28% of NTLA